[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Policy Perspectives
November 11, 1998

Complementary Medicine and the Cochrane Collaboration

Author Affiliations

From the Complementary Medicine Program, School of Medicine, University of Maryland, Baltimore (Drs Ezzo and Berman); Research Council for Complementary Medicine, London, England (Mr Vickers); and Center for Complementary Medicine Research, Technical University, Munich, Germany (Dr Linde).

JAMA. 1998;280(18):1628-1630. doi:10.1001/jama.280.18.1628

EVERY YEAR, millions of US consumers spend billions of dollars on alternative and complementary medical treatments.1 A similar trend exists in the United Kingdom and Australia.24 As people increasingly use these treatments, questions arise from consumers, clinicians, payers, and policymakers as to the effectiveness of these interventions.

First Page Preview View Large
First page PDF preview
First page PDF preview
×